Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trivalent COVID-19 Vaccine Booster in Healthy People in Colombia
NCT05433272Phase 3Unknown
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Status: unknown.
02
Drugs
Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05433272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433272.